Clinical Research Hub
Live Research Database

Psoriasis
Hub: Phoenix, AZ

Connecting patients in Phoenix with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Arizona

Available Psoriasis Opportunities

9 Recruiting
NCT06857942(Verify)

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

RECRUITING
Psoriasis
NCT07290569(Verify)

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

RECRUITING
Psoriasis
NCT07116967(Verify)

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

RECRUITING
Psoriasis
NCT06864026(Verify)

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

RECRUITING
Psoriasis
NCT02418442(Verify)

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

RECRUITING
Psoriasis
NCT06979453(Verify)

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

RECRUITING
Psoriasis
NCT06641089(Verify)

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

RECRUITING
Psoriasis
NCT06671496(Verify)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

RECRUITING
Psoriasis
NCT06671483(Verify)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

RECRUITING
Psoriasis

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Psoriasis research in Phoenix through safe, transparent, and patient-first clinical trials."

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT